1. Gao, F., Yamasaki, E.F., Chan, K.K., Shen, L.L., Snapka, R.M.: Chloroquinoxaline sulfonamide (NSC 339004) is a topoisomerase II α/β Poison. Cancer Res. 60, 5937–5940 (2000)
2. Hazeldine, S.T., Polin, L., Kushner, J., Paluch, J., White, K., Edelstein, M., Palomino, E., Corbett, T.H., Horwitz, J.P.: Design, synthesis, and biological evaluation of analogues of the antitumor agent, 2-(4-[(7-chloro-2-quinoxalinyl)oxy] phenoxypropionic acid (XK469)). J. Med. Chem. 44, 1758–1776 (2001)
3. Harms, E.: An efficient synthesis of 2-quinoxaline carboxylic acid. Org. Proc. Res. Dev. 8, 666–669 (2004)
4. Badran, M.M., Moneer, A.A., Refaat, H.M., El-Malah, A.A.: Synthesis and antimicrobial activity of novel quinoxaline derivatives. J. Chin. Chem. Soc. 54, 469–478 (2007)
5. El-Faham, A., El Massry, A., Amer, A., Gohar, Y.M.: A versatile synthetic route to chiral quinoxaline derivatives from amino acids precursors. Int. J. Pept. Res. Ther. 9, 49–54 (2002)